Gene signatures for cancer diagnosis and prognosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9605319
SERIAL NO

13819963

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MYRIAD GENETICS INC320 WAKARA WAY SALT LAKE CITY UT 84108

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gutin, Alexander Salt Lake City, US 77 268
Reid, Julia Salt Lake City, US 25 72
Stone, Steven Salt Lake City, US 31 145
Wagner, Susanne Salt Lake City, US 48 365

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00